Cancer
UNMC technologies in the oncology field available for licensing
Showing all 13 results
-
Anti-INHBA siRNA
Read more -
BRD4 and PI3K Dual Inhibitor
Read more -
MIBG Analogs
Read more -
CDK9 PROTACs
Read more -
Metformin nanoformulation
Read more -
Claudin-1 Inhibitors
Read more -
GGDPS Inhibitors
Read more -
Microtubule targeted therapeutics, imaging agents
Read more -
NF-κB Pathway Inhibitor
Read more -
CCL21-based immunotherapy for cancer
Read more -
Breast cancer biomarker
Read more -
NF-kB inhibitors
Read more -
Nanogel cancer treatment
Read more
